KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardelyx (ARDX) Cash & Equivalents (2016 - 2025)

Ardelyx (ARDX) has disclosed Cash & Equivalents for 12 consecutive years, with $68.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 4.72% year-over-year to $68.0 million, compared with a TTM value of $68.0 million through Dec 2025, up 4.72%, and an annual FY2025 reading of $68.0 million, up 4.72% over the prior year.
  • Cash & Equivalents was $68.0 million for Q4 2025 at Ardelyx, up from $42.7 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $96.1 million in Q4 2022 and bottomed at $21.5 million in Q4 2023.
  • Average Cash & Equivalents over 5 years is $58.8 million, with a median of $57.5 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents plummeted 77.67% in 2023, then soared 202.43% in 2024.
  • Year by year, Cash & Equivalents stood at $72.4 million in 2021, then soared by 32.74% to $96.1 million in 2022, then tumbled by 77.67% to $21.5 million in 2023, then skyrocketed by 202.43% to $64.9 million in 2024, then rose by 4.72% to $68.0 million in 2025.
  • Business Quant data shows Cash & Equivalents for ARDX at $68.0 million in Q4 2025, $42.7 million in Q3 2025, and $90.0 million in Q2 2025.